StuartFSeidesMD

Adult Congenital Heart Disease, Interventional Cardiology

Physician Chief Executive, MedStar Heart & Vascular Institute

Dr. Seides is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
110 Irving St NW
Suite 6D15H
Washington, DC 20010
Phone+1 202-877-2851

Fax+1 202-877-0829

I am the physician chief executive of MedStar Heart & Vascular Institute (MHVI), one of the highest volume heart and vascular care programs in the United States. I am responsible for all clinical services and administrative operations related to heart and vascular care delivered by MedStar Health and its affiliated physicians across the MedStar system in both the Washington and Baltimore regions, including the unique alliance between MHVI and the Cleveland Clinic Foundation. I am also a professor of Medicine at Georgetown.

My major clinical activities include consultative and interventional cardiology, including the initiation of the coronary angioplasty program at MWHC that has become one of the nation's largest.

MedStar Health/Georgetown-Washington Hospital CenterFellowship, Cardiovascular Disease, 1975 - 1976
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1974 - 1975
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1970 - 1972
Weill Cornell MedicineClass of 1970

PubMed

69 citations
Effect of atrial stimulation site on the electrophysiological properties of the atrioventricular node in man.
William P. Batsford, Masood Akhtar, Antonio R. Caracta, Mark E. Josephson, Stuart F. Seides
Circulation. 1974-08-01
163 citations
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.
Douglas R. Rosing, Kenneth M. Kent, Jeffrey S. Borer, Stuart F. Seides, B J Maron
Circulation. 1979-12-01
139 citations
Potential roles of osteopontin and alphaVbeta3 integrin in the development of coronary artery restenosis after angioplasty.
Dibyendu Kumar Panda, Gopal C. Kundu, Benjamin I. Lee, Alessandro Peri, David Fohl
Proceedings of the National Academy of Sciences of the United States of America. 1997-08-19

MedStar Heart & Vascular Institute Names Keki R. Balsara, MD, as Surgical Director of Heart Failure and TransplantationOctober 12th, 2022
MacGillivray Named Executive Director, Chairman of Cardiac Surgery at MedStar WashingtonMay 28th, 2022
MedStar Washington Hospital Center Ranks Among Nation’s Best for Heart CareAugust 18th, 2021
Join now to see all